Sfoglia per AUTORE
DEVOS T
Collezione AOU Novara

  

Items : 2

MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 10;41(32):4993-5004. doi: 10.1200/JCO.22.01972. Epub 2023 Mar 7.

2023
AOU Novara

Kiladjian JJ; Cui J; Salama ME; Colak G; Wondergem MJ; Hoffman R; Somervaille TCP; Granacher N; Scandura JM; Talpaz M; Hobbs G; Mead AJ; Rampal RK; Passamonti F; Devos T; Palandri F; Patriarca A; Kremyanskaya M; Mascarenhas J; Vannucchi AM; Verstovsek S; Curto-García N; Harrison C; Gupta V;

Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. in Future oncology (London, England) / Future Oncol. 2022 Sep;18(27):2987-2997. doi: 10.2217/fon-2022-0484. Epub 2022 Aug 11.

2022
AOU Novara

Harrison CN; Gupta VK; Gerds AT; Rampal R; Verstovsek S; Talpaz M; Kiladjian JJ; Mesa R; Kuykendall AT; Vannucchi AM; Palandri F; Grosicki S; Devos T; Jourdan E; Wondergem MJ; Al-Ali HK; Buxhofer-Ausch V; Alvarez-Larrán A; Patriarca A; Kremyanskaya M; Mead AJ; Akhani S; Sheikine Y; Colak G; Mascarenhas J;